<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#A8>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>Avasimibe</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>AVASIMIBE</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>FDA</n0:term-source><n0:source-code>28LQ20T5RC</n0:source-code></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P366>	"Avasimibe"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P108>	"Avasimibe"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Class> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P207>	"C0965226"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P210>	"166518-60-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://www.w3.org/2000/01/rdf-schema#label>	"Avasimibe"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P106>	"Pharmacologic Substance"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://linked.opendata.cz/ontology/mesh/hasConcept>	<http://linked.opendata.cz/resource/mesh/concept/M0383476> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://www.w3.org/2000/01/rdf-schema#subClassOf>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29703> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P322>	"FDA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P319>	"28LQ20T5RC"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P97>	"<n0:ComplexDefinition xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:def-definition>An orally bioavailable inhibitor of acyl-Coenzyme A:cholesterol acyltransferase (ACAT) that prevents cholesterol deposition in the arterial wall. Research was discontinued due to difficulties in assaying the effects of avasimibe on preventing plaque formation and due to its ability to increase the activity of Cytochrome P450 3A4, thus increasing the removal of other drugs from the body.</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P350>	"C29H43NO4S"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75252>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#code>	"C75252"^^<http://www.w3.org/2001/XMLSchema#string> .